 |
|
MUC-1 peptide vaccine
A cancer vaccine comprised of a synthetic peptide derived from the mucin 1 (MUC-1) antigen with potential antineoplastic activity. Upon administration, MUC-1 peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the MUC-1 antigen, resulting in decreased tumor growth. Overexpressed by many tumor cell types, MUC-1 antigen, a mammary-type apomucin, is a high-molecular-weight transmembrane glycoprotein. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Previous: | MS Contin, MSir, mTOR kinase inhibitor AZD8055, mTOR kinase inhibitor OSI-027, MUC-1 antigen | | Next: | MUC1-KLH conjugate vaccine, MUC1-KLH vaccine/QS21, Mucomyst, multi-epitope melanoma peptide vaccine, MultiHance |
|
|
